Nonutility of procalcitonin for diagnosing bacterial pneumonia in patients with severe COVID-19

Nonutility of procalcitonin for diagnosing bacterial pneumonia in patients with severe COVID-19

ABSTRACTBackground Patients hospitalized with COVID-19 are at significant risk for superimposed bacterial pneumonia. However, diagnosing superinfection is challenging due to its clinical resemblance to severe COVID-19. We therefore evaluated whether the immune biomarker, procalcitonin, could facilit...

Full description

Bibliographic Details
Main Authors: Avi J. Cohen, Laura R. Glick, Seohyuk Lee, Yukiko Kunitomo, Derek A. Tsang, Sarah Pitafi, Patricia Valda Toro, Nicholas R. Ristic, Ethan Zhang, George B. Carey, Rupak Datta, Charles S. Dela Cruz, Samir Gautam
Format: Article
Language:English
Published: Taylor & Francis Group 2023-01-01
Series:European Clinical Respiratory Journal
Subjects:
COVID-19
procalcitonin
critical care
bacterial superinfection
pneumonia
biomarker
Online Access:https://www.tandfonline.com/doi/10.1080/20018525.2023.2174640

Internet

https://www.tandfonline.com/doi/10.1080/20018525.2023.2174640

Similar Items